Platinum-resistant Ovarian Cancer (PROC)
Oncology
Prevalence
24.0 / 100K
Incidence
10.6 / 100K/yr
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Platinum-resistant Ovarian Cancer (PROC)?
There are 2 clinical trials targeting Platinum-resistant Ovarian Cancer (PROC) tracked by BioSniper.
What is the prevalence of Platinum-resistant Ovarian Cancer (PROC)?
The estimated prevalence of Platinum-resistant Ovarian Cancer (PROC) is approximately 24.0 per 100,000 population.
Deep-dive into Platinum-resistant Ovarian Cancer (PROC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis